Suvizumab is an experimental antiviral drug and immunomodulator. It is a monoclonal antibody that binds to HIV-1.[1]
References
- ^ "Proposed List number 102 of International Nonproprietary Names" (PDF). WHO Drug Information. 23 (4). Geneva: World Health Organization: 344. 2009. ISSN 1010-9609.
You must be logged in to post a comment.